Campillo, Jérémy T.
Louya, Frédéric
Bikita, Paul
Missamou, François
Pion, Sébastien D. S.
Boussinesq, Michel
Chesnais, Cédric B.
Funding for this research was provided by:
Agence Nationale de la Recherche (18-CE17-0008)
Article History
Received: 30 August 2022
Accepted: 2 October 2022
First Online: 9 November 2022
Declarations
:
: It was nested in a trial aimed at evaluating the safety and efficacy of single doses of levamisole in individuals infected with <i>L. loa</i>. This trial was approved by the Committee on Ethics in Health Sciences Research (no. 226/MRSIT/IRSSA/CERRSSA) and an Administrative Authorization (no. 469/MSP/CAB/UCPP-19) was released by the Ministry of Health and Population of the Congo.
: Not applicable.
: The authors declare that they have no competing interests.